| 标题 |
Talazoparib plus enzalutamide versus placebo plus enzalutamide in metastatic androgen pathway modulator-resistant (castration-resistant) prostate cancer (TALAPRO-2): a biomarker analysis of circulating tumour DNA and cells for prognosis and molecular profiling |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Yip SM; Laird AD; Agarwal N; Zschäbitz S; Fizazi K; et al 出版日期:2026/10/28 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)